13F Holdings
中文EN

ESMC ESCALON MEDICAL CORP

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 862668 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.4%
TTM net income YoY4,528.3%
TTM EPS YoY1,700.0%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR81.5%

Margins

Gross margin44.1%
Operating margin3.8%
Net margin32.8%
FCF margin0.8%
EBITDA margin3.9%

Returns

ROE114.9%
ROA61.7%
ROIC (approx.)22.8%
Asset turnover1.88x

Leverage & solvency

Liabilities / assets38.4%
Debt / equity0.00x
Current ratio2.72x
Interest coverage149.58x

Cash quality & payout

Operating cash flow / net income0.03x
Accruals ratio60.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$12.74M$12.05M$11.98M$12.18M$10.70M
Cost of revenue$7.17M$6.54M$6.84M$6.70M$6.10M
Gross profit$5.57M$5.51M$5.15M$5.48M$4.61M
R&D expense$501,488$753,130$688,189$818,769$990,982
SG&A expense$5.02M$4.62M$4.56M$4.18M$4.09M
Operating income$45,235$133,217-$104,476$478,543-$470,063
Interest expense$7,459$22,692$20,785$21,717$18,406
Pretax income$2.87M$105,525———
Income tax-$1.14M$0$0$0$0
Net income$4.01M$105,525-$125,261$456,826$18,081
EBITDA$67,823$171,036-$58,461$523,745-$421,631
EPS (basic)0.270.00-0.020.030.00
EPS (diluted)0.270.00-0.020.030.00
Weighted avg. shares (diluted)14.60M14.25M7.42M13.56M13.22M
Balance sheet
Cash & equivalents$3.07M$545,835$209,033$889,674$593,869
Receivables$1.90M$1.50M$2.12M$1.65M$1.54M
Inventory$1.73M$2.14M$1.61M$1.59M$1.60M
Current assets$7.01M$4.61M$4.40M$4.64M$4.19M
PP&E, net$26,605$34,589$48,878$34,064$52,660
Intangibles$8,134$29,792$49,442$69,986$82,750
Total assets$9.13M$4.99M$4.76M$5.31M$5.17M
Current liabilities$2.39M$2.69M$2.67M$2.85M$3.00M
Short-term debt———$0$201,575
Total liabilities$3.20M$3.08M$2.95M$3.37M$3.69M
Shareholders' equity$5.93M$1.92M$1.81M$1.93M$1.48M
Shares outstanding7.42M7.42M7.42M7.42M7.42M
Cash flow statement
Operating cash flow-$402,604$380,725-$602,771$325,146-$1.05M
Capital expenditure$4,421$3,880$40,285$6,687$0
Free cash flow-$407,025$376,845-$643,056$318,459-$1.05M
Investing cash flow$2.80M-$3,880-$40,285-$13,842$0
Financing cash flow-$129,892-$39,915-$37,456-$15,371-$6,931
Depreciation & amortization$22,588$37,819$46,015$45,202$48,432

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.